Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06515964
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-17
Brief Title:
China Early Esophageal Cancer Cohort
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Development and Validation of a Curability Evaluation Model for Endoscopic Resection of Early Esophageal Squamous Cell Carcinoma Based on China Early Esophageal Cancer Cohort
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
With the development of endoscopy more and more patients with superficial esophageal squamous cell carcinoma ESCC receive endoscopic resection rather than traditional surgery However there is still no complete consensus on the risk factors for lymph node metastasis LNM and recurrence of ESCC after endoscopic resection The existing curative resection criteria are strict to a certain extent and a considerable number of patients are overtreated according to the current standard of additional treatment Thus we aim to conduct a multi-center retrospective and prospective study to construct a large cohort of ESCC based on the previously established multi-center collaborative research network and clinical big data analyze the risk factors of LNM and recurrence in patients with early esophageal squamous cell carcinoma after ESD establish an accurate and simple risk prediction model and evaluate the discrimination efficiency of this model
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None